3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer

NCT00064051 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: gemcitabine hydrochloride
DRUG: triapine

Sponsor

Vion Pharmaceuticals